Berry Genomics Co.,Ltd. Posted 12.2 Million Yuan Net Loss in First Quarter of 2022

Berry Genomics Co.,Ltd. (成都市贝瑞和康基因技术股份有限公司) (000710.SZ) reported a net loss of 12.2 million yuan in the first quarter of 2022, reversing a net profit of 20.9 million yuan for the same period in the previous year.

Meanwhile, the company posted 313.5 million yuan in revenue, down 6.4% year-on-year.

At the end of the reporting period, it had 3.4 billion yuan in total assets and 941.7 million yuan in total liabilities, with a liability-to-asset ratio of 27.4%.